Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

10828	Companies
234903	Keywords
163763	Articles
125735	Press releases

Home
Companies
Jaguar Health, Inc.

BRIEF

published on 03/02/2026 at 15:05, 5 months 10 days ago

Record Date for Jaguar Health's Special One-time Stock Dividend

Crofelemer Preferred Stock Jaguar Health Stock Dividend Debt Restructuring
PRESS RELEASE

published on 03/02/2026 at 15:00, 5 months 10 days ago

Reminder: Today, March 2, 2026, is the Record Date for Jaguar Health's Special One-time Stock Dividend
Jaguar Health issues a Special Stock Dividend to provide dilution protection to shareholders as part of debt restructuring efforts. Preferred Stock payment date on March 4, 2026

Shareholders Preferred Stock Jaguar Health Debt Restructuring Special Stock Dividend
BRIEF

published on 02/18/2026 at 15:05, 5 months 22 days ago

Jaguar Health annonce un dividende exceptionnel en actions

Crofelemer Jaguar Health Restructuration De La Dette Dividende En Actions Insuffisance Intestinale
BRIEF

published on 02/18/2026 at 15:05, 5 months 22 days ago

Jaguar Health Declares Special One-Time Stock Dividend

Crofelemer Jaguar Health Stock Dividend Debt Restructuring Intestinal Failure
PRESS RELEASE

published on 02/18/2026 at 15:00, 5 months 22 days ago

Jaguar Health Announces a Special One-time Stock Dividend
Jaguar Health, Inc. declares special stock dividend to protect shareholders from dilution as company undertakes debt restructuring. Board's decision aligns with strategic focus on crofelemer intestinal failure program

Jaguar Health Debt Restructuring Special Stock Dividend Dilution Protection Crofelemer Program
BRIEF

published on 02/12/2026 at 15:52, 6 months ago

Jaguar Health Secures Licensing Agreement with Future Pak

Crofelemer Licensing Agreement Jaguar Health Mytesi Future Pak
BRIEF

published on 02/12/2026 at 15:52, 6 months ago

Jaguar Health conclut un accord de licence avec Future Pak

Crofelemer Jaguar Health Mytesi Contrat De Licence Future Pak
PRESS RELEASE

published on 02/12/2026 at 15:47, 6 months ago

Original-Research: Jaguar Health Inc (von First Berlin Equity Research GmbH): BUY
First Berlin Equity Research updates BUY recommendation for Jaguar Health Inc. Analyst Christian Orquera lowers target price to USD 7.50 due to licensing agreement with Future Pak and focus on core drug development

Jaguar Health Inc First Berlin Equity Research Buy Recommendation Research Update Christian Orquera
BRIEF

published on 01/22/2026 at 15:05, 6 months 21 days ago

Jaguar Health fait progresser le crofélémer dans le traitement des maladies d'insuffisance intestinale

Crofelemer Jaguar Health Approbation De La FDA Maladies Rares Insuffisance Intestinale
BRIEF

published on 01/22/2026 at 15:05, 6 months 21 days ago

Jaguar Health Advances Crofelemer for Intestinal Failure Diseases

Crofelemer FDA Approval Jaguar Health Rare Diseases Intestinal Failure

Accesswire

Published on 08/13/2026 at 00:30, 48 minutes ago

Aton Closes CAD$4 Million Private Placement
Published on 08/12/2026 at 23:30, 1 hour 48 minutes ago

CCL Industries Announces Record Results for 2026 Second Quarter
Published on 08/12/2026 at 23:30, 1 hour 48 minutes ago

Bolt Metals to Rebrand as 26 Metals Inc. and Adopt the Ticker "IRON," Highlighting Its Focus on Flagship Florália Iron Project in Brazil's Iron Quadrangle
Published on 08/12/2026 at 23:20, 1 hour 58 minutes ago

RJK Explorations Ltd. Announces Upsize of Previously Announced Private Placement
Published on 08/12/2026 at 23:05, 2 hours 13 minutes ago

Vox Royalty Reports Q2 2026 Results And Declares Quarterly Dividend

View all ACCESSWIRE

EQS Group

Published on 08/13/2026 at 01:05, 12 minutes ago

Pepperstone Appoints New CTO to Drive AI-Native Proprietary Tech Push
Published on 08/12/2026 at 21:05, 4 hours 12 minutes ago

Aurisco Pharmaceutical is the First Generic Oligonucleotide Manufacturer in the World successfully inspected by USFDA
Published on 08/12/2026 at 19:57, 5 hours 20 minutes ago

EQS-Adhoc: Hypoport SE: Hypoport SE resolves share buyback programme with a volume of up to EUR 10 million
Published on 08/12/2026 at 19:37, 5 hours 40 minutes ago

EQS-Adhoc: Brockhaus Technologies AG: Preliminary revenue for H1 2026 at €13.4 million and adjusted EBITDA at €-0.5 million; forecast for the continuing operations unchanged
Published on 08/12/2026 at 18:50, 6 hours 27 minutes ago

Holding(s) in Company

Les Echos

Published on 08/11/2026 at 17:45, 1 day 7 hours ago

DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 1 day 7 hours ago

Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 2 days 7 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 2 days 7 hours ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Published on 08/10/2026 at 17:45, 2 days 7 hours ago

Weekly share buyback

View all LES ECHOS COMFI WIRE